% | $
Quotes you view appear here for quick access.

Curis, Inc. Message Board

  • biglabowski99 biglabowski99 Sep 22, 2012 9:38 AM Flag

    su2c update triple trial

    30 month milestones
    The Team has fully enrolled the 842 patients for its double blind phase III clinical trial and data analysis has begun. The phase II clinical trial of a three-drug combination therapy for patients with advanced pancreatic cancer has continued and, after 6 months follow up, the Team observes a partial response in 33% of the patients and stable disease in another 48% of the patients.

    first time i have seen this

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.760.00(0.00%)Oct 26 4:00 PMEDT